에 대한 최신 뉴스 Dynatrace (NYSE:DT) 주식

DYNATRACE INC

Dynatrace

Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.

palantir shutter

News

Movers

AXON

AZPN

FTNT

KVUE

MSFT

NTRA

PLTR

SHOP

UBER

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 쇼피파이(NYSE:SHOP)는 강력한 실적 보고서와 2024년 3분기의 낙관적 전망에 따라 주가가 41.15% 상승했다. 몇몇 분석가들은 주식의 목표 주가를 수정했다.

쇼피파이 및 팔란티어는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (8월 4일-8월 10일)

Dynatrace Inc

EA Series Trust Sparkline International Intangible Value ETF

Delta Resources Ltd

Data3 Ltd

DTE Energy Company 2020 Series G 4.375% Junior Subordinated Debentures due 2080

Solo Brands Inc

DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC

Defence Therapeutics Inc

Dometic Group AB

Davis Commodities Limited - Ordinary Shares

Davis Commodities Ltd

DIRECT COATING INC by Direct Coating, Inc.

Global X Data Center & Digital Infrastructure ETF

DEUTSCHE WOHNEN UNSP/ADR by Deutsche Wohnen SE

Deutsche Wohnen SE

WisdomTree U.S. Total Dividend Fund

DELTA DJAKARTA TBK by DELTA DJAKARTA TBK

DTE Energy Co

DAVIDsTEA Inc

ALPS ETF Trust ALPS Disruptive Technologies ETF

DEUTSCHE TELEKOM AG REG by Deutsche Telekom AG

Deutsche Telekom AG

DEUTSCHE TELEKOM AG S/ADR by Deutsche Telekom AG

DITEM EXPLS INC by Ditem Explorations Inc.

Ditem Explorations Inc

DECOIN

DATA EVOLUTION HLDGS INC by Data Evolution Holdings, Inc.

Data Evolution Holdings Inc

DTF Tax-Free Income 2028 Term Fund Inc. Common Stock

DTF Tax-Free Income 2028 Term Fund Inc

DTE Energy Company 2021 Series E 4.375% Junior Subordinated Debentures

DAIMLER TRUCK HLDG AG by DAIMLER TRUCK HLDG AG

Daimler Truck Holding AG

DIGERATI TECHS INC by Digerati Technologies, Inc.

Digerati Technologies Inc

WisdomTree International High Dividend Fund

DTHERA SCIENCES by Dthera Sciences

Drilling Tools International Corporation - Common Stock

Drilling Tools International Corp

DEFENSE TECH INTL CP by Defense Technologies International Corp.

Defense Technologies International Corp

Precision BioSciences, Inc. - Common Stock

Precision BioSciences Inc

BROOKFIELD DTLA 7.625A PR by Brookfield DTLA Inc.

Brookfield DTLA Fund Office Trust Investor Inc

D2L Inc

DT Midstream Inc

DataMetrex AI Ltd

DATAMETREX AI LIMIT by Datametrex Ai Limit

DOUTOR NICHIRES HLDGS CO by Doutor Nichires Holdings Co., Ltd.

Doutor Nichires Holdings Co Ltd

DNO ASA

Directa Plus PLC

First Trust Alerian Disruptive Technology Real Estate ETF

DATELINE RESOURCES LTD by DATELINE RESOURCES LTD.

Dateline Resources Ltd

DATATRAK INTL INC by DATATRAK International, Inc.

DATATRAK International Inc

DETROIT LEGAL NEWS CO by Detroit Legal News Co.

Detroit Legal News Co

Deltron Inc

DAIMLER TRUCK HLDG S/ADR by DAIMLER TRUCK HLDG AG

DELIVERY TECHNOLOGY SLTNS by Delivery Technology Solutions, Inc.

Delivery Technology Solutions Inc

DTS Corp

DT Cloud Star Acquisition Corporation - Ordinary Shares

DT Cloud Star Acquisition Corp

DT Cloud Star Acquisition Corporation - Right

DT Cloud Star Acquisition Corporation - Units

PURPOSE ETHER STKING ETF by PURPOSE ETHER STAKING CORP. ETF

Datasea Inc

Data Storage Corp

Datatec Ltd

DATATEC LTD SA UNSP/ADR by Datatec Ltd. S.A.

DITO CME HOLDINGS CORP by Dito CME Holdings Corp.

Dish TV India Ltd

DESTINY PHARMA HLDGS PLC by Destiny Pharma Hldgs PLC

Destiny Pharma PLC

DTE Energy Company 2017 Series E 5.25% Junior Subordinated Debentures due 2077

DAETWYLER HOLDINGS AG ORD by Daetwyler Holdings AG

Daetwyler Holding AG

D2 Lithium Corp

Databroker

DELTEX MEDICAL GRP PLC by Deltex Medical Group plc.

Deltex Medical Group PLC

DOTZ NANO LTD S/ADR by Dotz Nano Ltd.

Dotz Nano Ltd

<p>B of A Securities  analyst Michael Carrier   maintains Tradeweb Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>) with a Buy and raises the price target from $197 to $212.</p>


Price Target

Analyst Ratings

B of A Securities Maintains Buy on Tradeweb Markets, Raises Price Target to $212

<p>Needham  analyst Mike Cikos   reiterates Cognyte Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNT#NASDAQ">CGNT</a>) from Hold to Hold.</p>


Reiteration

CGNT

Needham Reiterates Hold on Cognyte Softwareto Hold

<p>Deep-pocketed investors have adopted a bearish approach towards Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMAT usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Applied Mat. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 22% leaning bullish and 77% bearish. Among these notable options, 5 are puts, totaling $355,796, and 4 are calls, amounting to $506,989.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $135.0 to $220.0 for Applied Mat during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Applied Mat options trades today is 693.22 with a total volume of 990.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Applied Mat's big money trades within a strike price range of $135.0 to $220.0 over the last 30 days.</p>
<h3>Applied Mat Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743614849_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$9.7</td>
<td>$9.6</td>
<td>$9.6</td>
<td>$145.00</td>
<td>$421.4K</td>
<td>304</td>
<td align="right">456</td>
</tr>
<tr>
<td>AMAT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$8.25</td>
<td>$8.15</td>
<td>$8.15</td>
<td>$145.00</td>
<td>$221.6K</td>
<td>525</td>
<td align="right">286</td>
</tr>
<tr>
<td>AMAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$26.9</td>
<td>$26.0</td>
<td>$26.05</td>
<td>$170.00</td>
<td>$39.0K</td>
<td>1.5K</td>
<td align="right">16</td>
</tr>
<tr>
<td>AMAT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$57.15</td>
<td>$55.65</td>
<td>$57.15</td>
<td>$195.00</td>
<td>$34.2K</td>
<td>307</td>
<td align="right">6</td>
</tr>
<tr>
<td>AMAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.6</td>
<td>$5.4</td>
<td>$5.52</td>
<td>$160.00</td>
<td>$33.1K</td>
<td>678</td>
<td align="right">98</td>
</tr>
</tbody>
</table>
</p>
<h3>About Applied Mat</h3>
<p>Applied Materials Inc is the largest semiconductor wafer fabrication equipment, or WFE, manufacturer in the world. Applied Materials has a broad portfolio spanning nearly every corner of the WFE ecosystem. Specifically, Applied Materials holds a market share leadership position in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.</p>
<p>Following our analysis of the options activities associated with Applied Mat, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Applied Mat</h3>
<ul>
<li>With a volume of 2,208,774, the price of AMAT is up 2.4% at $149.16. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 43 days.</li>
</ul>
<h3>What Analysts Are Saying About Applied Mat</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $195.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Jefferies upgraded its action to Buy with a price target of $195. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Applied Mat with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

AMAT

Check Out What Whales Are Doing With AMAT

<p>Deep-pocketed investors have adopted a bullish approach towards Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DAL usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 18 extraordinary options activities for Delta Air Lines. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $559,507, and 13 are calls, amounting to $863,932.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $30.0 to $55.0 for Delta Air Lines over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Delta Air Lines's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Delta Air Lines's whale trades within a strike price range from $30.0 to $55.0 in the last 30 days. </p>
<h3>Delta Air Lines Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743614844_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DAL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$7.35</td>
<td>$7.15</td>
<td>$7.15</td>
<td>$40.00</td>
<td>$357.5K</td>
<td>1.5K</td>
<td>500</td>
</tr>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$2.14</td>
<td>$2.1</td>
<td>$2.1</td>
<td>$50.00</td>
<td>$151.7K</td>
<td>1.6K</td>
<td>2.3K</td>
</tr>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$4.6</td>
<td>$4.55</td>
<td>$4.6</td>
<td>$55.00</td>
<td>$117.3K</td>
<td>24</td>
<td>481</td>
</tr>
<tr>
<td>DAL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$5.8</td>
<td>$5.7</td>
<td>$5.7</td>
<td>$47.00</td>
<td>$101.4K</td>
<td>235</td>
<td>208</td>
</tr>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$2.1</td>
<td>$2.08</td>
<td>$2.08</td>
<td>$50.00</td>
<td>$93.8K</td>
<td>1.6K</td>
<td>1.3K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Delta Air Lines</h3>
<p>Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.</p>
<h3>Where Is Delta Air Lines Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 4,637,936, with DAL's price up by 1.7%, positioned at $43.14.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 7 days.</li>
</ul>
<h3>Expert Opinions on Delta Air Lines</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $70.2.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays persists with their Overweight rating on Delta Air Lines, maintaining a target price of $80.<br />
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on Delta Air Lines, maintaining a target price of $60.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Delta Air Lines, which currently sits at a price target of $72.<br />
&#x2A; An analyst from Raymond James persists with their Strong Buy rating on Delta Air Lines, maintaining a target price of $62.<br />
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Delta Air Lines, which currently sits at a price target of $77. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Delta Air Lines, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


What the Options Market Tells Us About Delta Air Lines

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Adobe</strong>.</p>
<p>Looking at options history for Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) we detected 13 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 38% with bearish.</p>
<p>From the overall spotted trades, 6 are puts, for a total amount of $283,549 and 7, calls, for a total amount of $258,625.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $285.0 and $470.0 for Adobe, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Adobe's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Adobe's whale activity within a strike price range from $285.0 to $470.0 in the last 30 days. </p>
<h3>Adobe Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743614838_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$93.45</td>
<td>$89.0</td>
<td>$89.0</td>
<td>$470.00</td>
<td>$89.0K</td>
<td>105</td>
<td align="right">10</td>
</tr>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$4.2</td>
<td>$4.05</td>
<td>$4.07</td>
<td>$350.00</td>
<td>$81.4K</td>
<td>1.5K</td>
<td align="right">208</td>
</tr>
<tr>
<td>ADBE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$7.75</td>
<td>$7.4</td>
<td>$7.57</td>
<td>$400.00</td>
<td>$74.9K</td>
<td>858</td>
<td align="right">107</td>
</tr>
<tr>
<td>ADBE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$102.35</td>
<td>$101.2</td>
<td>$101.79</td>
<td>$285.00</td>
<td>$40.7K</td>
<td>0</td>
<td align="right">10</td>
</tr>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$83.6</td>
<td>$82.4</td>
<td>$83.6</td>
<td>$465.00</td>
<td>$33.4K</td>
<td>357</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About Adobe</h3>
<p>Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).</p>
<h3>Current Position of Adobe</h3>
<ul>
<li>Trading volume stands at 1,181,612, with ADBE's price up by 0.94%, positioned at $386.8.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 71 days.</li>
</ul>
<h3>What Analysts Are Saying About Adobe</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $462.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Baird persists with their Neutral rating on Adobe, maintaining a target price of $410.<br />
&#x2A; An analyst from Citigroup persists with their Neutral rating on Adobe, maintaining a target price of $430.<br />
&#x2A; An analyst from Keybanc persists with their Underweight rating on Adobe, maintaining a target price of $390.<br />
&#x2A; An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Adobe, which currently sits at a price target of $550.<br />
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $530.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Adobe with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


ADBE

Unpacking the Latest Options Trading Trends in Adobe

<p>B of A Securities  analyst Craig Siegenthaler   maintains Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) with a Buy and raises the price target from $103 to $105.</p>


NDAQ

B of A Securities Maintains Buy on Nasdaq, Raises Price Target to $105

<p>Citigroup  analyst Christopher Allen   maintains Stifel Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SF#NYSE">SF</a>) with a Neutral and lowers the price target from $125 to $105.</p>


Citigroup Maintains Neutral on Stifel Financial, Lowers Price Target to $105

<p>HC Wainwright &amp; Co.  analyst Ed Arce   reiterates Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) with a Buy and maintains $13 price target.</p>


HC Wainwright & Co. Reiterates Buy on Inventiva, Maintains $13 Price Target

<p>B of A Securities  analyst Eli Abboud   maintains MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) with a Underperform and raises the price target from $189 to $191.</p>


MKTX

B of A Securities Maintains Underperform on MarketAxess Holdings, Raises Price Target to $191

<p><strong>FORT LAUDERDALE, FL / </strong><a href="https://www.accessnewswire.com/"><strong>ACCESS Newswire</strong></a><strong> / April 2, 2025 / </strong>Sunshine Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced that it has entered into definitive agreements in a registered direct offering with institutional investors for the purchase and sale of approximately $2.46 million of shares of Common Stock and pre-funded warrants at a price of $2.07 per share of Common Stock. The entire transaction has been priced at the market under Nasdaq rules.</p>
<p>The offering consisted of the sale of 1,188,404 shares of Common Stock (or Pre-Funded Warrants). The offering price per Common Share is $2.07 (or $2.069 for each Pre-Funded Warrant, which is equal to the offering price per share of Common Stock to be sold in the offering minus an exercise price of $0.001 per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full.</p>


Offerings

SBFM

Sunshine Biopharma Announces $2.46M Registered Direct Offering At $2.07 A Share

<p><strong>Bonk</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>) is up 5% on Wednesday, with traders anticipating the <a href="https://www.benzinga.com/money/bonk-bonk-price-prediction">rally to continue further</a>.</p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
<td><strong>Gains +/-</strong></td>
</tr>
<tr>
<td><strong>Bonk</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>)</td>
<td>$0.00001259</td>
<td>+4.7%</td>
</tr>
<tr>
<td><strong>Dogecoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1759</td>
<td>+1.1%</td>
</tr>
<tr>
<td><strong>Shiba Inu</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001281</td>
<td>-1.3%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>What Happened:</strong> Crypto trader Cold Blooded Shiller pointed out that BONK has experienced a massive sweep of the lows, testing a historically significant level.</p>
<p>He emphasized that stability and confirmation are needed before confidence can build for a larger move.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/search?q=%24BONK&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BONK</a> is another market I think is an interesting position with a huge attack on all of the lows.<br /><br />It needs to find some stability through this historic level to solidify.<br /><br />Relative simple TA, but still some work to be done here to increase confidence. <a href="https://t.co/AuqsitgrUC">pic.twitter.com/AuqsitgrUC</a></p>
<p>&mdash; Cold Blooded Shiller (@ColdBloodShill) <a href="https://twitter.com/ColdBloodShill/status/1906833368861626854?ref_src=twsrc%5Etfw">March 31, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>Analyst Crypto Chase <a href="https://x.com/Crypto_Chase/status/1907372326158578037">stated</a> that he is still holding 1% of his BONK position, watching how it interacts with the monthly support level that previously triggered a strong rally. </p>
<p>This is its first retest in over a year, and he expects the meme coin to bounce towards more than $0.02 over time. </p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44604076/why-are-dogecoin-shiba-inu-down-over-15-in-the-past-week">Why Are Dogecoin, Shiba Inu Down Over 15% In The Past Week?</a></strong></p>
<p><strong>Why It Matters:</strong> Bonk's price movement coincides with its recent <a href="https://x.com/bonk_inu/status/1905243483558015306?s=46">acquisition</a> of Exchange Art Marketplace, a major platform in the digital art sector. </p>
<p>This strategic move could expand BONK's real-world utility, strengthen its presence within Solana's creator economy and drive long-term value growth as use cases increase.</p>
<p>Prominent trader Unipcs <a href="https://x.com/theunipcs/status/1907189126937395295">highlighted</a> Bonk's strength as one of the top-performing tokens in the top 100.</p>
<p>Another trader <a href="https://x.com/degengambleh/status/1907451385936855388">believes</a> it has the potential to join Dogecoin and Pepe in the $100 billion club at the market cycle's peak.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44403417/floki-dogecoin-shiba-inu-lead-in-meme-coin-holder-profitability-as-market-returns-to-valuation-from-6-months-ago">Floki, Dogecoin, Shiba Inu Lead In Meme Coin Holder Profitability As Market Returns To Valuation From 6 Months Ago</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BONK

$DOGE

$SHIB

Bonk Surges 5% In A Day, Outpacing Dogecoin, Shiba Inu: What's Driving The Rally?

<p>Citigroup  analyst Christopher Allen   maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Neutral and lowers the price target from $60 to $50.</p>


HOOD

Citigroup Maintains Neutral on Robinhood Markets, Lowers Price Target to $50

<p>B of A Securities  analyst Craig Siegenthaler   maintains Intercontinental Exchange (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) with a Buy and lowers the price target from $237 to $230.</p>


B of A Securities Maintains Buy on Intercontinental Exchange, Lowers Price Target to $230

<p>Citigroup  analyst Christopher Allen   maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Neutral and lowers the price target from $180 to $150.</p>


Citigroup Maintains Neutral on Raymond James Finl, Lowers Price Target to $150

<p>B of A Securities  analyst Craig Siegenthaler   maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Underperform and raises the price target from $200 to $219.</p>


B of A Securities Maintains Underperform on CME Group, Raises Price Target to $219

<p>Citigroup  analyst Christopher Allen   maintains LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) with a Buy and lowers the price target from $415 to $400.</p>


LPLA

Citigroup Maintains Buy on LPL Finl Hldgs, Lowers Price Target to $400

<p>B of A Securities  analyst Eli Abboud   maintains BGC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGC#NASDAQ">BGC</a>) with a Buy and lowers the price target from $16 to $15.</p>


B of A Securities Maintains Buy on BGC Group, Lowers Price Target to $15

<p><a href="https://www.globenewswire.com/Tracker?data=D67Cyxpuji0BkATi8Y-GGTRirkXcYcIDKaHk9jy0OVJZ9GZrUAiptqf2vCbbpMrJjlx8wLdzowgYVuia9rFuARklxdQyrqazYRrsb9VKME0=">Arcutis Biotherapeutics, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQT#NASDAQ">ARQT</a>), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, is pleased to announce that Padagis Israel Pharmaceuticals Ltd., Padagis US LLC, and Padagis LLC (Padagis) have requested a stay to the ongoing patent litigation between Padagis and the Company, and the Company has agreed to enter a joint stipulation to stay the case, which was filed in the U.S. District Court for the District of Delaware on April 2, 2025. After the Court enters the joint stipulation, all calendared dates and trial for the patent litigation will be vacated.</p>
<p>As part of the joint stipulation agreement, Padagis is required to report to Arcutis any U.S. Food and Drug Administration (FDA) correspondence regarding their Abbreviated New Drug Application (ANDA) for their potential generic alternative to Arcutis' patented product, ZORYVE&#xAE; (roflumilast) cream 0.3% for plaque psoriasis. In addition, the parties agreed to extend the 30-month Hatch-Waxman stay of regulatory approval by one day for every day the litigation is stayed as of March 24, 2025, such that in the event the litigation resumes in the future, Arcutis will still benefit from the entirety of the stay afforded to it under the Hatch-Waxman Act.</p>
<p>"This joint stipulation is a positive development for Arcutis that fully preserves our ability to assert our intellectual property while also preserving the Hatch-Waxman stay. As we have previously communicated, we maintain confidence in the strength of our broad patent portfolio that protects the innovative aspects of ZORYVE and in our legal position against Padagis. If and when the stay is lifted, we will continue to vigorously defend our intellectual property rights as appropriate, and to fight against any attempts by Padagis to infringe our patents," said Frank Watanabe, president and CEO, Arcutis. "Our focus is to continue to build upon the strong adoption of ZORYVE as a safe and effective therapy and alternative to steroids for three major inflammatory dermatoses and continue to deliver meaningful innovation to millions of individuals impacted by plaque psoriasis, seborrheic dermatitis and atopic dermatitis."</p>


ARQT

Arcutis And Padagis Announces Agreement To Stay Patent Lawsuit

<p>Citigroup  analyst Christopher Allen   maintains Interactive Brokers Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) with a Buy and lowers the price target from $242 to $215.</p>


IBKR

Citigroup Maintains Buy on Interactive Brokers Group, Lowers Price Target to $215

<p>Maxim Group  analyst Naz Rahman   initiates coverage on Nuvectis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCT#NASDAQ">NVCT</a>) with a Buy rating and announces Price Target of $17.</p>


Comments

Dynatrace

뉴스

에 대한 최신 뉴스 Dynatrace (NYSE:DT) 주식

일요일, 8월 11, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌